Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment

A randomized trial (VITACOG) in people with mild cognitive impairment (MCI) found that B vitamin treatment to lower homocysteine slowed the rate of cognitive and clinical decline. We have used data from this trial to see whether baseline omega-3 fatty acid status interacts with the effects of B vita...

Full description

Bibliographic Details
Main Authors:	Oulhaj, A, Jernerén, F, Refsum, H, Smith, A, De Jager, C
Format:	Journal article
Language:	English
Published:	IOS Press 2016

Similar Items

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
by: de Jager, C, et al.
Published: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010)

Omega 3 fatty acid for the prevention of cognitive decline and dementia
by: Emma Sydenham, et al.

Omega 3 fatty acid for the prevention of cognitive decline and dementia
by: Emma Sydenham, et al.
Published: (2012-01-01)

Homocysteine, B vitamins, and cognitive impairment
by: Smith, A, et al.
Published: (2016)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: A David Smith, et al.
Published: (2010-09-01)

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment
by: Holmes, HE, et al.
Published: (2024)

Role of depression in predicting time to conversion to mild cognitive impairment.
by: Dean, K, et al.
Published: (2014)

Role of depression in predicting time to conversion to mild cognitive impairment
by: Dean, K, et al.
Published: (2014)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
by: Oulhaj, A, et al.
Published: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
by: Oulhaj, A, et al.
Published: (2010)

THE ROLE OF DEPRESSION IN PREDICTING THE TIME TO DEVELOPMENT OF MILD COGNITIVE IMPAIRMENT: A COHORT STUDY
by: Dean, K, et al.
Published: (2012)

Predicting cognitive decline in mild cognitive impairment: the issue of biological markers
by: Giannakopoulos Panteleimon
Published: (2006-02-01)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
by: Natalia Roberto, et al.
Published: (2021-12-01)

Microstructural brain changes track cognitive decline in mild cognitive impairment
by: Emilie T. Reas, et al.
Published: (2018-01-01)

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment
by: Wilma A. Bainbridge, et al.
Published: (2019-12-01)

Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
by: Belina Nunes, et al.
Published: (2017-03-01)

Role of omega 3 fatty acid in chemo-therapy induced cognitive decline
by: Ayesha Shahid, et al.
Published: (2020-11-01)

Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia
by: Tau Ming Liew
Published: (2020-09-01)

Vitamin B-12 and cognition in the elderly.
by: Smith, A, et al.
Published: (2009)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
by: Jingjing Guan, et al.
Published: (2020-03-01)

Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline
by: Knut Hestad, et al.
Published: (2020-08-01)

Mediterranean diet and cognitive decline: what role for omega-3 polyunsaturated fatty acids?
by: Barberger-Gateau Pascale, et al.
Published: (2011-07-01)

Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia
by: Kazumi Satogami, et al.
Published: (2017-09-01)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
by: Lisa Y. Xiong, et al.
Published: (2021-09-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
by: Pia Kivisäkk, et al.
Published: (2023-03-01)

Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia
by: Catherine A. Morgan, et al.
Published: (2021-12-01)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
by: Martins, C, et al.
Published: (2005)

Olfactory Decline in Older Adults with Mild Cognitive Impairment with and without Comorbidities
by: Katerina Touliou, et al.
Published: (2021-11-01)

Functional decline of the precuneus associated with mild cognitive impairment: Magnetoencephalographic observations.
by: Koichi Yokosawa, et al.
Published: (2020-01-01)

Altered cortical and subcortical morphometric features and asymmetries in the subjective cognitive decline and mild cognitive impairment
by: Jin Yang, et al.
Published: (2023-12-01)

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women
by: Diana Müller‐Gerards, et al.
Published: (2019-12-01)

Blood pressure in dementia, mild cognitive impairment, and subjective cognitive decline related to time of death
by: Knut Asbjørn Hestad, et al.
Published: (2021-07-01)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
by: Amir H Meghdadi, et al.
Published: (2021-01-01)

Detection and Prevention of Mild Cognitive Impairment and Dementia
by: Lambros Messinis, et al.
Published: (2023-08-01)

The Effect of Golghand (Rosadamacena) on Cognitive Status of Elderly with Mild Cognitive Impairment
by: Fatemeh Kameli, et al.
Published: (1401-10-01)